Jorge Wagner, President Director at Boehringer Ingelheim Indonesia, explains the importance of innovation within the universal healthcare coverage program that is being implemented in Indonesia. He also illustrates how the affiliate has been one of the fastest-growing pharmaceutical companies in Indonesia during the period 2015-2016.
With recent changes at the global level, including the business unit swap with Sanofi and the recent appointment of Hubertus von Baumbach - the first CEO from the founding family in 25 years - how have these changes affected you on the ground in Indonesia?
"Boehringer Ingelheim has been one of the fastest-growing players within the top 20 pharmaceutical companies in Indonesia for the past two years."
